Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06891287 | An Early Phase Study of RT-114 | PHASE1 | NOT YET_RECRUITING | 60 | — | — | May 1, 2025 | Mar 1, 2026 | Mar 23, 2025 | - | — |
| Name | Type | Description |
|---|---|---|
| RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity | COMBINATION_PRODUCT | RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity. |
| PG-102 | DRUG | PG-102 is a drug for the treatment of obesity. |
| Placebo | OTHER | The placebo is the RaniPill with saline instead of a drug. |